Anakinra in Refractory Multisystem Inflammatory Syndrome in Children (MIS-C)

Indian Pediatr. 2021 Oct 15;58(10):994-996. doi: 10.1007/s13312-021-2340-1.

Authors

Chandrika S Bhat¹, Rakshay Shetty², Deepak Ramesh², Afreen Banu², Athimalaipet V Ramanan³

Affiliations

¹ Pediatric Rheumatology Services, Rainbow Children's Hospital, Bangalore, Karnataka, India. chandrika.s.bhat@gmail.com.
² Pediatric Intensive Care Services, Rainbow Children's Hospital, Bangalore, Karnataka, India.
³ Bristol Royal Hospital for Children and Translational Health Sciences, University of Bristol, United Kingdom.

No abstract available

MeSH terms

COVID-19* / complications
Child
Humans
Ichthyosiform Erythroderma, Congenital*
Interleukin 1 Receptor Antagonist Protein / therapeutic use
SARS-CoV-2
Systemic Inflammatory Response Syndrome

Substances

Interleukin 1 Receptor Antagonist Protein

Supplementary concepts

pediatric multisystem inflammatory disease, COVID-19 related